Brackett Partners - Strategic Intelligence

Q: What does Brackett Partners do?

Brackett Partners is a strategic advisory firm backed by AI-powered predictive intelligence, with three sides: Advisory (customer-validated strategy for leadership teams), Agency (Digital CMO leadership and marketing execution at scale with Hawke Media), and M&A Advisory (sell-side M&A advisory in partnership with Britehorn Securities, Member FINRA/SIPC). The firm also serves the public sector at the state and federal level.

Q: How do Brackett engagements work?

One way of working, every engagement: Diagnose (evidence first — a structured, customer-validated read), Direct (findings become ranked priorities with defined decision points), and Deliver (Brackett stays accountable to the roadmap). No packages or pre-scoped offers — every engagement is shaped after a conversation and gated phase by phase.

Q: Who does Brackett Partners serve?

Clients range from venture-backed companies to Fortune-ranked enterprises to state and federal institutions, across Healthcare & MedTech, Industrial & Manufacturing, Consumer & Hospitality, Technology & Venture-Backed, and the Public Sector.

Q: What is CVX SCAN?

CVX SCAN® is a Brackett Advisory service powered by the Luminas CVX SCAN® methodology: a 4-6 week structured, qualitative customer value assessment that identifies where a company holds differential value and which customer-driven growth opportunities to prioritize.

Q: What is Brackett's Predictive Intelligence capability?

AI-powered market research and analytics delivered in partnership with OSG Analytics: ASEMAP future-behavior modeling, choice modeling with willingness-to-pay curves and market simulation, adoption drivers analysis, and real-time analytics with segments delivered into the client's CRM.

Brackett Partners

All Case Studies

Medical TechnologyProduct Concept Testing

Product Concept Testing for Hazardous Drug Detection

Global Medical Devices Company|Global Enterprise

High

Likelihood of adoption

4

Countries validated

Identified

Top adoption drivers

Prioritized

Benefit messaging

The Challenge

Needed to test a new concept for detecting hazardous drug contamination in pharmacies, understand key benefits, and estimate adoption potential.

concept testingmedtechadoptionbenefit prioritizationunmet needshazardous drug contamination

The Solution

Quantitative Concept Testing + Benefit Prioritization

AI-driven analytics
Quantitative research with pharmacy directors/managers
Key driver analysis
Unmet-need assessment
Country comparison

The Results

Found strong adoption potential and clarified the benefits most likely to differentiate the concept.

High

Likelihood of adoption

4

Countries validated

Identified

Top adoption drivers

Prioritized

Benefit messaging

Functional Areas

Product DevelopmentMarket ResearchCommercialization

Want the Full Implementation Playbook?

Get the complete case study with detailed methodology, implementation timeline, specific frameworks used, and lessons learned.

Sound Familiar?

This Case Study May Be Relevant If You're Saying...

1

"We need to test a new product concept"

2

"We do not know which benefits will drive adoption"

3

"We need early commercialization evidence"

Discuss Your Challenge

Related Case Studies

Medical Technology

Customer-Centric Transformation

Needed to shift from product-centered decisions to customer-centered operations amid slowing growth, weak differentiation, and complex buying audiences.

View Case Study

Medical Technology

Customer Engagement Optimization for Dentsply Sirona

Needed to optimize customer engagement across the dental professional journey, identify the highest-impact CX initiatives, quantify willingness to pay for improvements, and align investments to the strongest revenue and loyalty drivers.

View Case Study

Ready to See Results Like These?

Let's Discuss Your Challenge

Every engagement starts with understanding your specific situation. Request a consultation to explore how we can help.

Request Consultation